Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-16T19:16:35.085Z Has data issue: false hasContentIssue false

How common? Exploring the prevalence and risk factors for Pseudomonas aeruginosa in diabetic foot infections among kidney transplant recipients

Published online by Cambridge University Press:  28 November 2025

Mario Escoriza Gonzalez
Affiliation:
Department of Internal Medicine, Montefiore Medical Center, Bronx, NY, USA
Daniel A. Burack
Affiliation:
Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA
Margaret McCort
Affiliation:
Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA
Phyu Thwe
Affiliation:
Department of Pathology, Montefiore Medical Center, Bronx, NY, USA
Luz Liriano-Ward
Affiliation:
Division of Nephrology, Department of Internal Medicine, Montefiore Medical Center, Bronx, NY, USA
Rohan Goyal
Affiliation:
Division of Infectious Diseases, Department of Medicine, New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA
Rachel Bartash*
Affiliation:
Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA
*
Corresponding author: Rachel Bartash; Email: rbartash@montefiore.org

Abstract

Objective:

Concern for Pseudomonas aeruginosa in diabetic foot infections (DFIs) is common and a driving factor for empiric antibiotic prescribing, particularly among immunocompromised hosts. This study sought to identify the prevalence of Pseudomonas aeruginosa in DFIs among kidney transplant recipients and the use of antipseudomonal agents for empiric antibiotic coverage.

Design:

Retrospective cohort study.

Setting:

Large, urban, tertiary care transplant center.

Patients:

39 kidney transplant recipients who developed DFIs at our institution between 2015–2023.

Methods:

We performed a retrospective review of 47 DFIs in 39 kidney transplant recipients hospitalized for a DFI with a positive tissue culture.

Results:

A total of 79 organisms were isolated. Pseudomonas represented 6.33% of organisms (5/79) and was present in 5/47 DFIs (10.6%). Staphylococcus aureus was the most commonly isolated organism (30.4%, 24/79). Compared to those with non-Pseudomonas infections, patients with cultures positive for Pseudomonas were temporally closer to transplant (50.6 days +/- 214.9 vs 1047.6 days +/- 766.4, p = 0.041) and more likely to have been treated for rejection with the past 12 months (2/5, 40% vs 0/42, 0%, p = 0.009). Eighty three percent of patients received empiric antibiotic coverage with an antipseudomonal agent.

Conclusions:

Our study found a low overall prevalence of Pseudomonas in DFIs among kidney transplant recipients. Despite this, empiric coverage with antipseudomonal antibiotics was common, highlighting a potential antimicrobial stewardship target in solid organ transplantation.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Demographics, risk factors, and outcomes of kidney transplant recipients with diabetic foot infections secondary to Pseudomonas aeruginosa compared to other organisms

Figure 1

Figure 1.Organisms isolated from diabetic foot infections (n = 79).